In this microlearning module, an expert faculty provides an overview of the cardiorenal benefits of SGLT2 inhibitors in patients with type 2 diabetes.
A leading expert provides an overview of the cardiorenal benefits of SGLT2 inhibitors in patients with type 2 diabetes.
Dr Jennifer B. Green summarizes key findings that underpin use of SGLT2 inhibitors in patients with diabetic kidney disease.
In this microlearning module, an expert faculty provides an overview of the cardiorenal benefits of finerenone in patients with type 2 diabetes and chronic kidney disease.
A leading expert provides an overview of the cardiorenal benefits of finerenone in patients with type 2 diabetes and chronic kidney disease.
Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, summarizes key findings that underpin the use of finerenone in patients with diabetic kidney disease.
In this microlearning module, an expert faculty provides an overview of the considerations for management of CKD associated with T2D, with a focus on pharmacotherapy options.
A leading expert provides an overview of the considerations for management of CKD associated with T2D, with a focus on pharmacotherapy options.
Dr Vivian Fonseca provides insights on how to tailor the management of type 2 diabetes (T2D) and chronic kidney disease (CKD) for your individual patients, including treatment recommendations for high-risk patients and those with concurrent cardiovascular disease.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.